Skip to content
MEO NextGenDeveloper StudioDEV
  1. Dashboard
  2. Additional Insights
  3. Drug
  4. #31

Additional Insight · Drug · Review / Edit

Anti-D immunoglobulin in antepartum haemorrhage

Record #31 · Edit the content, source and classification relationships.

PreviousNext
SQL status stored
Candidate visibility Not candidate-visible
Type Drug
Related questions 8
Additional Insights list

Additional Insight #31

Currently stored: stored

Status control does not offer the stored value. This record is stored as stored, but this legacy control only offers generated / needs_review / approved / retired. Saving will submit the selected value (currently generated) and replace stored.

This is a known backend issue reported separately; it has not been changed in this visual redesign.

Source

UUID — protected
0acd6bac-d007-44b7-8adc-fc6505456349
Cancel

Classification Relationships — through Subtopic3

2 assigned
Obstetrics and Gynaecology→ Clinical→ Delivery suite→ Haemorrhage→ Antepartum haemorrhage→ General→ RhD-negative anti-D prophylaxis
Obstetrics and Gynaecology→ Clinical→ Delivery suite→ Haemorrhage→ Antepartum haemorrhage→ General→ Rhesus prophylaxis

Related Questions (8)

Matched through Subtopic3
SSBAQ65 generated
An RhD-negative woman at 31 weeks presents with a significant antepartum haemorrhage. She has no anti-D antibodies. Which investigation is specifically required to determine whether additional anti-D immunoglobulin is necessary?
Delivery suite → Haemorrhage → Antepartum haemorrhage → General → Rhesus prophylaxis
Open Question
SSBAQ76 generated
A non-sensitised RhD-negative woman at 30 weeks has recurrent episodes of antepartum haemorrhage. She received anti-D immunoglobulin following an earlier episode three weeks ago. She now presents with another significant bleed. Which statement is most appropriate?
Delivery suite → Haemorrhage → Antepartum haemorrhage → General → Rhesus prophylaxis
Open Question
SSBAQ136 generated
An unsensitised RhD-negative woman at 34 weeks has a significant APH. A standard dose of anti-D immunoglobulin is given. Kleihauer testing subsequently demonstrates a fetomaternal haemorrhage exceeding that covered by the administered dose. What is the most appropriate next step?
Delivery suite → Haemorrhage → Antepartum haemorrhage → General → Rhesus prophylaxis
Open Question
SSBAQ166 generated
An unsensitised RhD-negative woman has recurrent APH at 29, 31 and 33 weeks. She received anti-D after the first episode. Following the third episode, a colleague argues that no further prophylactic assessment is necessary because all three bleeds probably arise from the same placental pathology. Which principle is most appropriate?
Delivery suite → Haemorrhage → Antepartum haemorrhage → General → Rhesus prophylaxis
Open Question
SSBAQ170 generated
An unsensitised RhD-negative woman at 33 weeks presents with painful APH and uterine tenderness. Ultrasound demonstrates no retroplacental collection. Kleihauer testing shows a significant fetomaternal haemorrhage. Which interpretation is most accurate?
Delivery suite → Haemorrhage → Antepartum haemorrhage → General → Rhesus prophylaxis
Open Question
EEMQQ218 generated
Select the single most appropriate approach to rhesus prophylaxis.
Delivery suite → Haemorrhage → Antepartum haemorrhage → General → Rhesus prophylaxis
Open Question
EEMQQ230 generated
Select the single most appropriate investigation to determine whether additional anti-D immunoglobulin is required.
Delivery suite → Haemorrhage → Antepartum haemorrhage → General → Rhesus prophylaxis
Open Question
EEMQQ261 generated
Select the single most appropriate rhesus-management principle.
Delivery suite → Haemorrhage → Antepartum haemorrhage → General → RhD-negative anti-D prophylaxis
Open Question